Device Makers Should Seek Familiarity With Biodefense Agencies – AdvaMed
This article was originally published in The Gray Sheet
Executive Summary
Developers of medical devices with possible biodefense applications will have a second opportunity to submit applications for National Institute of Allergy & Infectious Diseases biodefense partnerships after the initial NIH Jan. 24 deadline
You may also be interested in...
CDRH Emergency Product List Update May Result From Manufacturer Survey
Manufacturers submitting comments on FDA's device shortage survey by Feb. 28 will have an opportunity to alter the agency's emergency product list
High-Tech Devices, Representatives Excluded From HHS Bioterror Plans
Device industry reps are working with FDA to determine which types of products remain unaddressed by HHS Secretary Tommy Thompson's bioterrorism command center
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”